Speech temporal organization in three basal ganglia-related neurological conditions
DOI:
https://doi.org/10.1590/1678-460x202258946Keywords:
dysarthria; speech acoustics; articulation disorders; movement disorders; phoneticsAbstract
Basal ganglia participate in neural networks that control voluntary body movements, including speech. Diseases that affect the function of these structures can generate abnormal hypokinetic or hyperkinetic movements, influencing speech motor control. How does prosodic temporal organization vary in dysarthria due to Parkinson’s disease (PD), Huntington’s disease (HD), and Sydenham’s chorea (SC)? Three clinical groups (PD with and without medication, HD, and SC) of 15 participants and a control group (n = 18) read a text aloud. Speech fluency measures were related to syntactic boundaries within the text. There was no correlation between global motor scales and temporal parameters of speech. There were correlations between syntactic limits and the duration of pauses in all groups. Only the HD results differed from the other clinical and control groups. Clinical groups are slower to produce speech but preserve the syntactic function of prosody at different levels. Basal nuclei dysfunction appears to affect all clinical groups, regardless of etiology.
References
Angelis, E. C. (2006). Voz e deglutição na doença de Parkinson. In L. A. F. Andrade, E. R. Barbosa, F. Cardoso, & H. A. G. Teive (Eds.), Doença de Parkinson: estratégias atuais do tratamento (pp. 197-207). Segmento Farma.
Angelis, E. C., Irineu, R. A., & Vilanova, L. C. P. (1997). Coréia de Sydenham - Avaliação fonoarticulatória. Pró Fono, 9(2), 17-21. Azevedo, L. L. (2001). Aspectos prosódicos da fala do parkinsoniano
[Master thesis]. Federal University of Minas Gerais.
Azevedo, L. L. (2007). Expressão da atitude através da prosódia em indivíduos com doença de Parkinson idiopática [Doctoral
dissertation]. University of Minas Gerais.
Azevedo, L. L., Cardoso, F., & Reis, C. (2003). Análise acústica da
prosódia em mulheres com doença de Parkinson: comparação com controles normais. Arquivos de Neuro-Psiquiatria, 61(4), 999-1003. https://doi.org/10.1590/s0004-282x2003000600021.
Barkmeier-Kraemer, J. M., & Clark, H. M. (2017). Speech-language pathology evaluation and management of hyperkinetic disorders affecting speech and swallowing function. Tremor and Other Hyperkinetic Movements, 7, 489. https://doi.org/10.5334/tohm.381.
Beato, R., Maia, D. P., Teixeira, A. L., & Cardoso, F. (2010). Executive functioning in adult patients with Sydenham’s chorea. Movement Disorders, 25(7), 853-857. https://doi.org/10.1002/mds.23154.
Boersma, P. W., & Weenink, D. (2009). Praat: doing phonetics by computer [Computer software]. http://www.praat.org/.
Brabenec, L., Mekyska, J., Galaz, Z., & Rektorova, I. (2017). Speech disorders in Parkinson’s disease: Early diagnostics and effects of medication and brain stimulation. Journal of Neural Transmission, 124(3), 303-334.
https://doi.org/10.1007/s00702-017-1676-0.
Bunton, K., Kent, R. D., Kent, J. F., & Rosenbek, J. C. (2000). Perceptuo-acoustic assessment of prosodic impairment in dysarthria. Clinical Linguistics & Phonetics, 14(1), 13-24. https://doi. org/10.1080/026992000298922.
Cardoso, F. (2009). Huntington disease and other choreas. Neurologic Clinics, 27(3), 719-736. https://doi.org/10.1016/j.ncl.2009.04.001.
Cardoso, F., Eduardo, C., Silva, A. P., & Mota, C. C. C. (1997). Chorea in fifty consecutive patients with rheumatic fever. Movement Disorders, 12(5), 701-703. https://doi.org/10.1002/mds.870120512.
Cardoso, F., Seppi, K., Mair, K. J., Wenning, G. K., & Poewe, W. (2006). Seminar on choreas. The Lancet Neurology, 5(7), 589-602. https:// doi.org/10.1016/s1474-4422(06)70494-x.
Cardoso, F., Vargas, A. P., Oliveira, L. D., Guerra, A. A., & Amaral, S. V. (1999). Persistent Sydenham’s chorea. Movement Disorders, 14(5), 805-807. https://doi.org/10.1002/1531-8257(199909)14:5<805::AID- MDS1013>3.0.CO;2-P.
Cavallieri, F., Budriesi, C., Gessani, A., Contardi, S., Fioravanti, V., Menozzi, E., Pinto, S., Moro, E., Valzania, F., & Antonelli, F. (2021). Dopaminergic treatment effects on dysarthric speech: Acoustic analysis in a cohort of patients with advanced Parkinson’s disease. Frontiers in Neurology, 11. 616062. https://doi.org/10.3389/ fneur.2020.616062.
Chan, J. C. S., Stout, J. C., & Vogel, A. P. (2019). Speech in prodromal and symptomatic Huntington’s disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases. Neuroscience and Biobehavioral Reviews, 107, 450-460. https://doi. org/10.1016/j.neubiorev.2019.08.009.
Chu, S. Y., Barlow, S. M., Lee, J., & Wang, J. (2019). Effects of utterance rate and length on the spatiotemporal index in Parkinson’s disease. International Journal of Speech-Language Pathology, 22(2), 141-151. https://doi.org/10.1080/17549507.2019.1622781.
Cushnie-Sparrow, D., Adams, S., Abeyesekera, A., Pieterman, M., Gilmore, G., & Jog, M. (2018). Voice quality severity and responsiveness to levodopa in Parkinson’s disease. Journal of Communication Disorders, 76, 1-10. https://doi.org/10.1016/j.jcomdis.2018.07.003.
Darley, F. L. (1975). Diagnosis of motor speech disorders. Australian Journal of Human Communication Disorders, 3(1), 19-27. https:// doi.org/10.3109/asl2.1975.3.issue-1.03.
Darley, F. L., Aronson, A. E., & Brown, J. R. (1969). Differential diagnostic patterns of Dysarthria. Journal of Speech and Hearing Research, 12(2), 246-269. https://doi.org/10.1044/jshr.1202.246.
De Letter, M., Santens, P., Estercam, I., Van Maele, G., De Bodt, M., Boon, P., & Van Borsel, J. (2007). Levodopa‐induced modifications of prosody and comprehensibility in advanced Parkinson’s disease as perceived by professional listeners. Clinical Linguistics & Phonetics, 21(10), 783-791. https://doi.org/10.1080/02699200701538181.
Defebvre, L. (2005). La maladie de Parkinson. In C. Ozsancak, & P. Auzou (Eds.), Les troubles de la parole et de la déglutition dans la maladie de Parkinson (pp. 09-28). Solal.
Defebvre, L. (2007). La maladie de Parkinson et les syndromes parkinsoniens. In P. Auzou, V. Rolland-Monnoury, S. Pinto, & C. Ozsancak (Eds.), Les Dysarthries (pp. 165-168). Solal.
Diehl, S. K., Mefferd, A. S., Lin, Y.-C., Sellers, J., McDonell, K. E., de Riesthal, M., & Claassen, D. O. (2019). Motor speech patterns in Huntington disease. Neurology, 93(22), e2042-e2052. https://doi. org/10.1212/wnl.0000000000008541.
Duez, D. (2005). Organisation temporelle de la parole et dysarthrie parkinsonienne. In C. Ozsancak, & P. Auzou (Eds.), Les troubles de la parole et de la déglutition dans la maladie de Parkinson (pp. 195-213). Solal.
Duez, D. (2007). Proposition por une typologie et une évaluation acoustique des faits de dysprosodie. In P. Auzou, V. Rolland-Monnoury, S. Pinto, & C. Ozsancak (Eds.), Les Dysarthries (pp. 123-126). Solal.
Duffy, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., & Stout, J. C. (2007). Psychiatric symptoms in Huntington’s disease before diagnosis: The predict-HD study. Biological Psychiatry, 62(12), 1341-1346. https://doi.org/10.1016/j.biopsych.2006.11.034.
Efron, B., & Tibshirani, R. J. (1994). An introduction to the bootstrap. CRC.
Fabbri, M., Guimarães, I., Cardoso, R., Coelho, M., Guedes, L. C., Rosa, M. M., Godinho, C., Abreu, D., Gonçalves, N., Antonini, A., & Ferreira, J. J. (2017). Speech and voice response to a levodopa challenge in late-stage Parkinson’s disease. Frontiers in Neurology, 8. 432. https://doi.org/10.3389/fneur.2017.00432.
Fahn, S. E., & Members of UPDRS Development Committee. (1987). Unified Parkinson’s disease rating scale. In S. Fahn, C. Marsden, D. Calne, & M. Goldstein (Eds.), Recent developments in Parkinson’s disease (pp. 153-163). Macmillan.
Ferraz, H. B. (2006). Distúrbios do movimento. In K. Z. Ortiz (Ed.), Distúrbios Neurológicos adquiridos: fala e voz (pp. 125-143). Manole. Goberman, A. M., & Blomgren, M. (2003). Parkinsonian speech disfluencies: Effects of l-dopa-related fluctuations. Journal of Fluency Disorders, 28(1), 55-70.
https://doi.org/10.1016/s0094-730x(03)00005-6.
Goberman, A. M., & Coelho, C. (2002). Acoustic analysis of Parkinsonian
speech II: L-Dopa related fluctuations and methodological issues. NeuroRehabilitation, 17(3), 247-254. https://doi.org/10.3233/nre- 2002-17311.
Goberman, A. M., & Elmer, L. W. (2005). Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease. Journal of Communication Disorders, 38(3), 215-230. https://doi. org/10.1016/j.jcomdis.2004.10.001.
Goberman, A., Coelho, C., & Robb, M. (2002). Phonatory characteristics of Parkinsonian speech before and after morning medication: The ON and OFF states. Journal of Communication Disorders, 35(3), 217-239.
https://doi.org/10.1016/s0021-9924(01)00072-7.
Goetz, C. G., Stebbins, G. T., Shale, H. M., Lang, A. E., Chernik, D. A., Chmura, T. A., Ahlskog, J. E., & Dorflinger, E. E. (1994). Utility of an objective dyskinesia rating scale for Parkinson’s disease: Inter- and intrarater reliability assessment. Movement Disorders, 9(4), 390-394. https://doi.org/10.1002/mds.870090403.
Group, H. S. (1996). Unified Huntington’s disease rating scale: Reliability and consistency. Movement Disorders, 11(2), 136-142. https://doi. org/10.1002/mds.870110204.
Hammen, V. L., & Yorkston, K. M. (1996). Speech and pause characteristics following speech rate reduction in hypokinetic dysarthria. Journal of Communication Disorders, 29(6), 429-445. https://doi.org/10.1016/0021-9924(95)00037-2.
Hammen, V. L., Yorkston, K. M., & Minifie, F. D. (1994). Effects of temporal alterations on speech intelligibility in parkinsonian dysarthria. Journal of Speech, Language, and Hearing Research, 37(2), 244-253. https://doi.org/10.1044/jshr.3702.244.
Hartelius, L., Carlstedt, A., Ytterberg, M., Lillvik, M., & Laakso, K. (2003). Speech disorders in mild and moderate Huntington disease: Results of dysarthria assessments of 19 individuals. Journal of Medical Speech- Language Pathology, 11, 1-15.
Hertrich, I., & Ackermann, H. (1994). Acoustic analysis of speech timing in Huntington′s disease. Brain and Language, 47(2), 182-196. https:// doi.org/10.1006/brln.1994.1048.
Hoff, J. I., van Hilten, B. J., & Roos, R. A. C. (1999). A review of the assessment of dyskinesias. Movement Disorders, 14(5), 737- 743. https://doi.org/10.1002/1531-8257(199909)14:5<737::AID- MDS1005>3.0.CO;2-A.
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico- pathological study of 100 cases. Journal of Neurology, Neurosurgery & Psychiatry, 55(3), 181-184. https://doi.org/10.1136/jnnp.55.3.181.
Illes, J. (1989). Neurolinguistic features of spontaneous language production dissociate three forms of neurodegenerative disease: Alzheimer’s, Huntington’s, and Parkinson’s. Brain and Language, 37(4), 628-642.
https://doi.org/10.1016/0093-934x(89)90116-8.
Lowit, A., Marchetti, A., Corson, S., & Kuschmann, A. (2018). Rhythmic performance in hypokinetic dysarthria: Relationship between reading, spontaneous speech and diadochokinetic tasks. Journal of Communication Disorders, 72, 26-39. https://doi.org/10.1016/j. jcomdis.2018.02.005.
Ludlow, C. L., Connor, N. P., & Bassich, C. J. (1987). Speech timing in Parkinson’s and Huntington’s disease. Brain and Language, 32(2), 195-214. https://doi.org/10.1016/0093-934x(87)90124-6.
Maia, D. P., Teixeira, A. L., Quintao Cunningham, M. C., & Cardoso, F. (2005). Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea. Neurology, 64(10), 1799-1801. https://doi.org/10.1212/01.wnl.0000161840.62090.0e.
Martinez-Sánchez F. (2010). Speech and voice disorders in Parkinson’s disease. Revista de Neurologia, 51(9), 542-550.
McRae, P. A., Tjaden, K., & Schoonings, B. (2002). Acoustic and perceptual consequences of articulatory rate change in Parkinson disease. Journal of Speech, Language, and Hearing Research, 45(1), 35-50.
https://doi.org/10.1044/1092-4388(2002/003).
Meynadier, Y., Lagrue, B., Mignard, P., & Viallet, F. (1999). Effects of L-Dopa treatment on the production and perception of parkinsonian vocal intonation. Parkinsonism and Related Disorders, 5(Supplement 1), S121.
Mignard, P., Cavé, C., Lagrue, B., & Meynadier, Y. (2001). Étude expérimentale des pauses silencieuses chez les parkinsoniens en production orale spontanée et en lecture. Revue de Neuropsychologie, 11, 39-63.
Mourão, L. F. (2006). Intervenção fonoaudiológica nos distúrbios do movimento. In K. Z. Ortiz (Ed.), Distúrbios Neurológicos Adquiridos: fala e voz (pp. 144-160). Manole.
Mourão, L.F., & Ferraz, H.B. (2003). Avaliação e tratamento dos distúrbios do movimento. In I. J. A. Rios (Ed.), Conhecimentos essenciais para atender bem em fonoaudiologia hospitalar (pp. 125-139). Pulso.
Murray, L. L. (2000). Spoken language production in Huntington’s and Parkinson’s diseases. Journal of Speech, Language, and Hearing Research, 43(6), 1350-1366. https://doi.org/10.1044/jslhr.4306.1350.
Oliveira, P. M. (2003). Estudos prosódicos da fala dos portadores de coreia de Sydenham [Master thesis]. Federal University of Minas Gerais.
Oliveira, P. M., Cardoso, F., Maia, D. P., Cunningham, M. C. Q., Teixeira Jr, A. L., & Reis, C. (2010). Acoustic analysis of prosody in Sydenham’s chorea. Arquivos de Neuro-Psiquiatria, 68(5), 744-748. https://doi. org/10.1590/s0004-282x2010000500013.
Özsancak, C. (2007). La dysarthrie dans la maladie de Huntington. In P. Auzou, V. Rolland-Monnoury, S. Pinto, & C. Ozsancak (Eds.), Les Dysarthries (pp. 183-186). Solal.
Pah, N. D., Motin, M. A., Kempster, P., & Kumar, D. K. (2021). Detecting effect of levodopa in Parkinson’s disease patients using sustained phonemes. IEEE Journal of Translational Engineering in Health and Medicine, 9, 1-9. https://doi.org/10.1109/jtehm.2021.3066800.
Perini, M. A. (1996). A gramática descritiva do português. Ática. Perini, M. A. (2006). Princípios de linguística descritiva: Introdução aopensamento gramatical. Parábola.
Pinho, P., Monteiro, L., Soares, M. F. de P., Tourinho, L., Melo, A., &
Nóbrega, A. C. (2018). Impact of levodopa treatment in the voice pattern of Parkinson’s disease patients: a systematic review and meta- analysis. CoDAS, 30(5). e20170200.
Pinto, S. (2009). Intérêt de l’utilisation de la tomographie par émission de positrons pour l’étude de la parole normale et pathologique. In A. Marchal, & C. Cavé (Eds.), L’imagerie médicale pour l’etude de la parole (pp. 215-236). Lavoisier.
Pinto, S., Ghio, A., Teston, B., & Viallet, F. (2010). La dysarthrie au cours de la maladie de Parkinson. Histoire naturelle de ses composantes: Dysphonie, dysprosodie et dysarthrie. Revue Neurologique, 166(10), 800-810. https://doi.org/10.1016/j.neurol.2010.07.005.
Pinto, S., Ozsancak, C., Tripoliti, E., Thobois, S., Limousin-Dowsey, P., & Auzou, P. (2004). Treatments for dysarthria in Parkinson’s disease. The Lancet Neurology, 3(9), 547-556. https://doi.org/10.1016/s1474- 4422(04)00854-3.
Poluha, P.C., Teulings, H.L., & Brookshire, R.H. (1998). Handwriting and speech changes across the levodopa cycle in Parkinson’s disease. Acta Psychologica, 100(1-2), 71-84. https://doi.org/10.1016/s0001- 6918(98)00026-2.
Ramig, L. O., Fox, C., & Sapir, S. (2008). Speech treatment for Parkinson’s disease. Expert Review of Neurotherapeutics, 8(2), 297-309. https:// doi.org/10.1586/14737175.8.2.297.
Reis, C., Gama, A. C. C., Cardoso, F., Teixeira, E. G., & Pereira, L. A. (2007). Organisation temporelle dans la parole chez des malades brésiliens atteints de la maladie de Parkinson. Travaux Interdisciplinaires Du Laboratoire Parole et Langage d’Aix-En- Provence (TIPA), 26, 131-152.
Rigaldie, K., Nespoulou, J. L., & Vigouroux, N. (2004). La prosodie chez les sujets parkinsoniens: Analyse de la production de la gamme musicale. Revue Parole, 31, 375-408.
Rosen, K. M., Kent, R. D., Delaney, A. L., & Duffy, J. R. (2006). Parametric quantitative acoustic analysis of conversation produced by speakers with dysarthria and healthy speakers. Journal of Speech, Language, and Hearing Research, 49(2), 395-411. https://doi.org/10.1044/1092- 4388(2006/031).
Rosin, B., Nevet, A., Elias, S., Rivlin-Etzion, M., Israel, Z., & Bergman, H. (2007). Physiology and pathophysiology of the basal ganglia- thalamo-cortical networks. Parkinsonism & Related Disorders, 13, S437-S439. https://doi.org/10.1016/s1353-8020(08)70045-2.
Ross, C. A., Reilmann, R., Cardoso, F., McCusker, E. A., Testa, C. M., Stout, J. C., Leavitt, B. R., Pei, Z., Landwehrmeyer, B., Martinez, A., Levey, J., Srajer, T., Bang, J., & Tabrizi, S. J. (2019). Movement disorder society task force viewpoint: Huntington’s disease diagnostic categories. Movement Disorders Clinical Practice, 6(7), 541-546. https://doi.org/10.1002/mdc3.12808.
Rusz, J., Klempíř, J., Baborová, E., Tykalová, T., Majerová, V., Čmejla, R., Růžička, E., & Roth, J. (2013). Objective acoustic quantification of phonatory dysfunction in Huntington’s disease. PLoS ONE, 8(6), e65881. https://doi.org/10.1371/journal.pone.0065881.
Rusz, J., Klempíř, J., Tykalová, T., Baborová, E., Čmejla, R., Růžička, E., & Roth, J. (2014a). Characteristics and occurrence of speech impairment in Huntington’s disease: Possible influence of antipsychotic medication. Journal of Neural Transmission, 121(12), 1529-1539. https://doi.org/10.1007/s00702-014-1229-8.
Rusz, J., Saft, C., Schlegel, U., Hoffman, R., & Skodda, S. (2014b). Phonatory dysfunction as a preclinical symptom of Huntington disease. PLoS ONE, 9(11), e113412. https://doi.org/10.1371/journal. pone.0113412.
Rusz, J., Tykalová, T., Klempíř, J., Čmejla, R., & Růžička, E. (2016). Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: Longitudinal follow-up study on previously untreated patients. Journal of Neural Transmission, 123(4), 379-387. https://doi.org/10.1007/s00702-016-1515-8.
Sanabria, J., Ruiz, P. G., Gutierrez, R., Marquez, F., Escobar, P., Gentil, M., & Cenjor, C. (2001). The effect of levodopa on vocal function in Parkinson’s disease. Clinical Neuropharmacology, 24(2), 99-102. https://doi.org/10.1097/00002826-200103000-00006.
Sapir, S. (2014). Multiple factors are involved in the dysarthria associated with Parkinson’s disease: A review with implications for clinical practice and research. Journal of Speech, Language, and Hearing Research, 57(4), 1330-1343. https://doi.org/10.1044/2014_ jslhr-s-13-0039.
Sapir, S., Ramig, L., & Fox, C. (2008). Speech and swallowing disorders in Parkinson disease. Current Opinion in Otolaryngology & Head and Neck Surgery, 16(3), 205-210. https://doi.org/10.1097/ moo.0b013e3282febd3a.
Skodda, S., Flasskamp, A., & Schlegel, U. (2010). Instability of syllable repetition as a model for impaired motor processing: Is Parkinson’s disease a “rhythm disorder”? Journal of Neural Transmission, 117(5), 605-612.
https://doi.org/10.1007/s00702-010-0390-y.
Skodda, S., Grönheit, W., & Schlegel, U. (2011). Intonation and speech rate in Parkinson’s disease: General and dynamic aspects and responsiveness to levodopa admission. Journal of Voice, 25(4), e199-e205. https://doi.org/10.1016/j.jvoice.2010.04.007.
Skodda, S., Rinsche, H., & Schlegel, U. (2009). Progression of dysprosody in Parkinson’s disease over time - A longitudinal study. Movement Disorders, 24(5), 716-722. https://doi.org/10.1002/mds.22430.
Skodda, S., & Schlegel, U. (2008). Speech rate and rhythm in Parkinson’s disease. Movement Disorders, 23(7), 985-992. https://doi.org/10.1002/ mds.21996.
Skodda, S., Schlegel, U., Hoffmann, R., & Saft, C. (2014). Impaired motor speech performance in Huntington’s disease. Journal of Neural Transmission, 121(4), 399-407. https://doi.org/10.1007/s00702-013- 1115-9.
Spencer, K. A., & Rogers, M. A. (2005). Speech motor programming in hypokinetic and ataxic dysarthria. Brain and Language, 94(3), 347- 366. https://doi.org/10.1016/j.bandl.2005.01.008.
Tasset, I., Sánchez, F., & Túnez, I. (2009). Bases moleculares de la enfermedad de Huntington: Papel del estrés oxidativo. Revista de Neurologia, 49(8), 424-429. https://doi.org/10.33588/ rn.4908.2009192.
Teixeira, A. L., Cardoso, F., Maia, D., & Cunningham, M. (2003). Sydenham’s chorea may be a risk factor for drug induced parkinsonism. Journal of Neurology, Neurosurgery & Psychiatry, 74(9), 1350-1351. https://doi.org/10.1136/jnnp.74.9.1350-a.
Teixeira, A. L., Maia, D. P., & Cardoso, F. (2005). UFMG Sydenham’s chorea rating scale (USCRS): Reliability and consistency. Movement Disorders, 20(5), 585-591. https://doi.org/10.1002/mds.20377.
Teixeira, E. G. (2008). Organização temporal da leitura oral na doença de Parkinson [Master thesis]. Federal University of Minas Gerais.
Teston, B., & Viallet, F. (2005). La dysprosodie parkinsonienne. In C. Ozsancak, & P. Auzou (Eds.), Les troubles de la parole et de la déglutition dans la maladie de Parkinson (pp. 161-193). Solal.
Thobois, S., & Peisson, S. (2007). La maladie de Huntington: de la clinique à la thérapeutique. In P. Auzou, V. Rolland-Monnoury, S. Pinto, & C. Ozsancak (Eds.), Les Dysarthries (pp. 179-182). Solal.
Tjaden, K., & Wilding, G. E. (2004). Rate and loudness manipulations in dysarthria. Journal of Speech, Language, and Hearing Research, 47(4), 766-783. https://doi.org/10.1044/1092-4388(2004/058).
Tumas, V., Caldas, C. T., Santos, A. C., Nobre, A., & Fernandes, R. M. F. (2007). Sydenham’s chorea: Clinical observations from a Brazilian movement disorder clinic. Parkinsonism & Related Disorders, 13(5), 276-283. https://doi.org/10.1016/j.parkreldis.2006.11.010.
Velasco-García, M. J., Cobeta, I., Martín, G., Alonso-Navarro, H., & Jimenez-Jimenez, F. J. (2011). Acoustic analysis of voice in Huntington’s disease patients. Journal of Voice, 25(2), 208-217. https://doi.org/10.1016/j.jvoice.2009.08.007.
Viallet, F., Teston, B., Jankowski, L., Purson, A., Peragut, J., Regis, J., & Wiitjas, T. (2002). Effects of pharmacological versus electrophysiological treatments on parkinsonian dysprosody. In Proceedings of the Speech Prosody (pp. 679-682). Laboratoire Parole et Langage.
Viallet, F., Teston, B., Jankowski, L., Purson, A., Meynadier, Y., & Lagrue, B. (2003). Analyse acoustique de la production vocale: Contribution à l’évaluation de la dysprosodie parkinsonienne. Revue de Neurologie.
Viallet, F., & Teston, B. (2007). La dysarthrie dans la maladie de Parkinson. In P. Auzou, V. Rolland-Monnoury, S. Pinto, & C. Ozsancak. Les Dysarthries (pp. 169-174). Solal.
Vogel, A. P., Shirbin, C., Churchyard, A. J., & Stout, J. C. (2012). Speech acoustic markers of early stage and prodromal Huntington’s disease: A marker of disease onset? Neuropsychologia, 50(14), 3273-3278. https://doi.org/10.1016/j.neuropsychologia.2012.09.011.
Volkmann, J., Hefter H, Lange HW, & Freund HJ. (1992). Impairment of temporal organization of speech in basal ganglia diseases. Brain and Language, 43(3), 386-399. https://doi.org/10.1016/0093- 934x(92)90108-q.
Whitfield, J. A., Reif, A., & Goberman, A. M. (2017). Voicing contrast of stop consonant production in the speech of individuals with Parkinson disease ON and OFF dopaminergic medication. Clinical Linguistics & Phonetics, 32(7), 587-594. https://doi.org/10.1080/02699206.20 17.1387816.
